In this study, the APP/PS1 double transgenic AD mouse model was used to investigate the pharmacodynamic effects and mechanisms of the dual-target liposome complex AD808 in Alzheimer’s disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.